Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer. [electronic resource]
Producer: 20121031Description: 41-6 p. digitalISSN:- 1095-6859
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Pilot Projects
- Prospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.